The dual roles of immunity in ALS: injury overrides protection

Neurobiology of Disease
Benjamin J MurdockEva L Feldman

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive, fatal neurodegenerative disease affecting motor neurons. Disease progression is accompanied by a multi-phased immune response, and recent studies indicate that the immune system is not simply a bystander during disease, but plays an active role in shaping ALS pathology. The role of the immune system during ALS progression is highly complex, however, as it has been found to have a role in both enhancing neurodegeneration as well as protecting the central nervous system. Previous reports have established that the immune response can therefore be separated into two distinct phases: a protective Type 2 response followed by a neurotoxic Type 1 response. This review will address the two phases of the immune response in ALS and describe their roles during disease progression. More importantly, it will also examine the likely sources of immune polarization that are responsible for shifting immunity from the protective T2 phase to the neurotoxic T1 phase.

References

Jan 1, 1993·Archives of Neurology·J I EngelhardtS H Appel
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·R G SmithS H Appel
Jan 16, 1999·Free Radical Biology & Medicine·K RutaultD R Katz
Jul 12, 2002·Nature·Paola ScaffidiMarco E Bianchi
Jan 4, 2003·Nature Reviews. Immunology·Siamon Gordon
Apr 30, 2003·Cell Death and Differentiation·E L TaylorA G Rossi
Oct 9, 2003·The EMBO Journal·Tiziana BonaldiMarco E Bianchi
May 12, 2004·Immunology Letters·Verónica Fernández-RuizNatalia López-Moratalla
Jul 24, 2004·EMBO Reports·Patrizia Rovere-QueriniAngelo A Manfredi
Aug 24, 2004·The Journal of Biological Chemistry·François Gros-LouisJean-Pierre Julien
Jan 7, 2005·Brain : a Journal of Neurology·Adriano ChiòGabriele Mora
Mar 8, 2005·Journal of Neuroimmunology·Guang-Xian ZhangAbdolmohamad Rostami
Dec 13, 2005·Molecular and Cellular Neurosciences·Jenny S HenkelStanley H Appel
Mar 7, 2006·Protein and Peptide Letters·Joerg Gsponer, Michele Vendruscolo
May 4, 2006·Journal of Physiology and Biochemistry·V Fernández-RuizA González
Jun 28, 2006·Annals of Neurology·Merit E CudkowiczDaniel B Drachman
Oct 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·David R BeersStanley H Appel
Feb 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Makoto UrushitaniJean-Pierre Julien
May 9, 2007·Nature Medicine·Rishi RakhitAvijit Chakrabartty
Jun 9, 2007·Journal of Neurochemistry·Qin XiaoStanley H Appel
Jul 12, 2007·JAMA : the Journal of the American Medical Association·John L ZellerRichard M Glass
Jul 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Arie GruzmanJian Liu
Jul 21, 2007·American Journal of Epidemiology·Honglei ChenFreya Kamel
Aug 11, 2007·Brain Research·Nobutoshi MorimotoKoji Abe
Aug 21, 2007·Nature Cell Biology·Asya RollsMichal Schwartz
Aug 28, 2007·The Journal of Comparative Neurology·Alain R Simard, Serge Rivest
Sep 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Wanda NiedbalaFoo Y Liew
Sep 25, 2007·Journal of Autoimmunity·Yufeng PengKeith B Elkon
Nov 6, 2007·Lancet Neurology·Paul H GordonUNKNOWN Western ALS Study Group

❮ Previous
Next ❯

Citations

Oct 31, 2015·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Apr 2, 2016·Experimental Neurology·Melanie M DasClive N Svendsen
May 27, 2015·Current Neurology and Neuroscience Reports·Martin R Turner, Esther Verstraete
Feb 26, 2016·Acta Neuropathologica·Lisa ZondlerJochen H Weishaupt
Sep 13, 2016·Immunology and Cell Biology·Lisa ZondlerJochen H Weishaupt
Oct 21, 2016·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Franck PatinHélène Blasco
Oct 21, 2016·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Rosa Luisa PotenzaLuisa Minghetti
Dec 24, 2015·Annals of Neurology·Kevin S ChenEva L Feldman
Jan 31, 2017·Journal of the Neurological Sciences·Xinglong YangYanming Xu
Oct 25, 2017·Journal of Neural Transmission·Caroline BaufeldOleg Butovsky
Jun 14, 2019·Expert Opinion on Investigational Drugs·Stephen A GoutmanEva L Feldman
Mar 20, 2020·Disease Models & Mechanisms·Valeria ValsecchiAlessandro Vercelli
Jun 20, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Jiangwei SunFang Fang
Nov 16, 2019·Journal of Neuroinflammation·Gabriela Bortolança ChiarottoAlexandre Leite Rodrigues de Oliveira
Sep 16, 2020·Journal of Neurology, Neurosurgery, and Psychiatry·Stephen A GoutmanEva L Feldman
Oct 31, 2017·Mediators of Inflammation·Massimo TortaroloCaterina Bendotti
Jun 15, 2019·International Journal of Molecular Sciences·Laura Moreno-MartinezRosario Osta
Dec 7, 2018·Scientific Reports·Brett A McGregorJunguk Hur
May 12, 2015·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·UNKNOWN ALSUntangled Group
Oct 7, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·J B DelayeH Blasco
Feb 4, 2021·Neurology. Neuroimmunology and Neuroinflammation·Benjamin J MurdockEva L Feldman
Jun 22, 2021·Neuroscience and Biobehavioral Reviews·Fabiola De MarchiLetizia Mazzini
Jun 4, 2021·Journal of Internal Medicine·Jiangwei SunFang Fang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.